e-Drug3D

187

METHSUXIMIDE

INN
METHSUXIMIDE

(has an active metabolite)

cas 39122-23-1

CLASS

NERVOUS SYSTEM
ANTICONVULSANT

ROUTE (list)

ORAL

ATC code

N03AD03

PK parameters

t1/2 1.4 HOUR

Target

-

Voltage-gated T-type calcium channel UNIPROT O43497 CACNA1G

Download SDF file

1,3-dimethyl-3-phenylpyrrolidine-2,5-dione

Formula:
C12H13NO2

Calculated chemical properties:

MW 203.23
NB_atoms 15
XLogP 1.33
PSA 37.967
NB_HD 0
NB_HA 3
fsp3 0.33
Lipinski(0=no;1=yes) 1

FDA
NDA 010596 (label) INN (METHSUXIMIDE) CELONTIN (PARKE DAVIS) APPROVAL= AP YEAR= 1957 NEWMOLECULARENTITY
NDA 217213 (pdf not found) INN (METHSUXIMIDE) METHSUXIMIDE (NOVITIUM PHARMA) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1762

M METHSUXIMIDE

INN
METHSUXIMIDE

(is an active metabolite)

cas 39122-10-6

CLASS

NERVOUS SYSTEM
ANTICONVULSANT

ROUTE (list)

-

ATC code

N03AD03

PK parameters

t1/2 38 HOUR

Target

-

Voltage-gated T-type calcium channel UNIPROT O43497 CACNA1G

Download SDF file

2,5-Pyrrolidinedione, 3-methyl-3-phenyl-, (3R)-

Formula:
C11H11NO2

Calculated chemical properties:

MW 189.21
NB_atoms 14
XLogP 0.99
PSA 49.324
NB_HD 1
NB_HA 3
fsp3 0.27
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1763

M METHSUXIMIDE

INN
METHSUXIMIDE

(is an active metabolite)

cas 39122-11-7

CLASS

NERVOUS SYSTEM
ANTICONVULSANT

ROUTE (list)

-

ATC code

N03AD03

PK parameters

t1/2 38 HOUR

Target

-

Voltage-gated T-type calcium channel UNIPROT O43497 CACNA1G

Download SDF file

2,5-Pyrrolidinedione, 3-methyl-3-phenyl-, (3S)-

Formula:
C11H11NO2

Calculated chemical properties:

MW 189.21
NB_atoms 14
XLogP 0.99
PSA 48.915
NB_HD 1
NB_HA 3
fsp3 0.27
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL